Viseven at Pharma Events: The September-October Recap Posted on November 3, 2023 by Andrii Nikulin Viseven’s mission as a global provider of MarTech services is to facilitate digital maturity and move innovation forward within organizations that play a crucial role in the evolution of pharma and life sciences worldwide, including Europe, the Middle East, North and South America, and Asia-Pacific (APAC). Viseven at Pharma Events: The September-October Recap Throughout many years, the number of our customers and partners in different domains of the pharmaceutical and life sciences industries has been increasing for one reason – we love networking! Every month, the Viseven team attends diverse industry events to explore the hottest trends and practices in the latest technology and omnichannel marketing. In September and October 2023, the Viseven team visited the United Arab Emirates (UAE), Japan, England, Germany, and Switzerland to attend the key events and learn more about the hottest trends and practices in omnichannel pharma marketing and technology. The 3rd International ACS Congress On September 15-16, 2023, Mehdi Ayadi, Account Executive at Viseven, attended the third International Congress of the American College of Surgeons in Dubai, UAE, to connect with companies and professionals exploring the most recent developments in surgical practices and research. Throughout the two days of the conference, attendees had an opportunity to see innovations from companies exhibiting healthcare services, medical equipment, and pharma products and take part in 17 sessions about the latest practices and insights in laparoscopic, bariatric, robotic, orthopedic, plastic, breast, pediatric, and other types of surgery. The congress’ scientific program included surgical research presentations, video-based education sessions showcasing surgical procedures, postgraduate courses, and workshops about best practices in surgical education and the latest training methods. Nearly 60 speakers from UAE, Saudi Arabia, Oman, Kuwait, Bahrain, Egypt, Tunisia, Jordan, Pakistan, the United Kingdom, Germany, and Canada shared their knowledge and experience across essential surgical specialties. Mehdi Ayadi connected with representatives of companies that offer healthcare solutions, medical technology, and pharmaceutical products and services to showcase the omnichannel marketing service and the digital content factory solution provided by Viseven. “The third International Congress of the American College of Surgeons is an event that brought lots of great opportunities. For Viseven, it’s an honor to be here and use these opportunities for networking. Many businesses worldwide and in the Middle East realize that personalization is the future of customer engagement. Our goal at the event was to demonstrate how it works in practice,” says Mehdi Ayadi, Account Executive at Viseven. ARABLAB 2023 On 19-21 September, Mehdi Ayadi attended one more spectacular event in Dubai – Arablab 2023, a conference where thousands of attendees engaged with over 1,000 exhibitors from 120 countries and 18 industries, including agriculture, chemical engineering, energy & environment, food testing, laboratory technology, material testing, nanotechnology, robotics & automation, and beyond. During the three days of the event, attendees could visit more than 50 seminars and learn more about intelligent digitalization tools for laboratory data, data security in the pharmaceutical industry, chemical safety awareness, drug detection in the dairy industry, real-time analysis of cellular metabolism, and other trending topics. Along with discovering how companies facilitate the growth in biotechnology, life sciences, drug discovery and development, and other domains related to healthcare, Mehdi was excited to network with some professionals to discuss the latest techniques in marketing personalization and show them digital solutions powered by Viseven. The 4th Annual CX Management for Life Science On October 12-13, Nataliya Andreychuk, Viseven CEO, visited Zurich to attend the fourth Annual CX Management for Life Science, one of the world’s central events that highlights the latest practices in delivering the best experiences for patients and healthcare professionals. At the event, attendees had an opportunity to join representatives of top pharma companies like Takeda, Pfizer, Merck, Sandoz, Bayer, and Roche in almost 20 panel discussions. On the first day of the event, Nataliya Andreychuk was a moderator at the panel called AI Challenges and How Embracing New Tech Will Impact Healthcare, where she discussed the latest transformations caused by artificial intelligence and machine learning within the current pharma landscape. “I was excited to host this panel. I discovered how top companies are implementing AI and made a few connections that will help Viseven implement AI within digital ecosystems of customers more efficiently,” says Nataliya Andreychuk. Storylines Tour by Contentful On October 19, Nataliya Andreychuk, Viseven CEO, was in Berlin to attend Storylines Tour by Contentful, a series of events that also happened in New York, Paris, London, and Silicon Valley. Storylines Tour in Berlin had a saturated agenda that included more than ten sessions where attendees could learn about eCommerce, AI for design, content engagement, customer experiences, personalized customer journeys, global digital experiences, and beyond. “Thanks, Paul Biggs and the rest of the Contentful team, who put such a great event together! I learned, had fun, and spent time with a variety of intelligent, fantastic people,” says Nataliya Andreychuk, Viseven CEO. Reuters Pharma Japan 2023 On October 24-25, Ethan Greely, Outbound Sales Development Representative at Viseven, and Inyong Lee, Senior Account Manager at Viseven, were in Tokyo to attend Reuters Pharma Japan, one of the most significant industry events in the APAC region. More than 55 speakers from the world’s top pharma companies, such as Sanofi, Novo Nordisk, Moderna, Pfizer, Takeda, Johnson & Johnson, and Bayer, hosted over 20 keynotes. The event’s visitors had a chance to learn more about sustainable healthcare ecosystems, patient centricity, digital promotion, big data, artificial intelligence, patient experiences, and other innovative trends in the pharma industry. As one of the event’s exhibitors, Viseven was excited to meet with attendees at its booth, where Ethan Greely and Inyong Lee showcased the possibilities of eWizard, a content experience platform developed by Viseven. “Reuters Pharma Japan 2023 was very fruitful for Viseven. We made several significant connections with representatives of pharma companies that have some bottlenecks in the production and delivery of their medical content. They liked eWizard’s functionality and want to examine its possibilities deeply in the near future,” says Inyong Lee, Senior Account Manager at Viseven. The 4th Annual Pharma AI Summit On October 26-27, Nataliya Andreychuk, CEO at Viseven, and Olena Volkova, Regional Director at Viseven, went to London to participate in the fourth Annual Pharma AI Summit and discover the latest trends in artificial intelligence and machine learning domains. Organized by GlobalBSG, the Annual Pharma AI Summit is one of the world’s most innovative events for healthcare, pharmaceuticals, biomedical, biotech, data analytics, and AI companies. The event united healthcare professionals, research scientists, data scientists, and C-level executives to share, explore, and generate insights and grasp the latest transformations caused by artificial intelligence in the pharmaceutical industry and life sciences. The summit covered the list of the hottest topics: AI & ML data infrastructure and architecture AI governance capabilities, data policies, and ethics AI and the clinical trial design and optimization Virtual patients, digital twins, and causal disease models AI integration for novel drug discovery A deep learning Library for sequential claims data The effects of RNA-small molecule interactions at scale Natural language processing for the detection of adverse events Along with examining the latest capabilities of AI in pharma, Nataliya Andreychuk and Olena Volkova connected with managers of different businesses to introduce eWizard Video Maker, an AI-powered add-on for eWizard. Nataliya and Olena personally demonstrated how it can convert presentations into videos and create videos from scratch with AI avatars. After the add-on demonstration, the reps of several companies agreed to continue negotiations on possible collaboration with Viseven. Viseven Lunch & Learn Beside different events all around the globe, the Viseven team organizes its own events to share professional expertise and knowledge in pharma marketing. On October 25, Viseven, in collaboration with Marketing-Sales Executives of the Pharmaceutical-Healthcare Industry (MEPI), arranged an exclusive custom-tailored workshop in Manila, Philippines — Digital Marketing Transformation Journey — to empower marketing and sales executives with knowledge and skills. Lunch & Learn is a series of workshops that help dozens of professionals to explore the current digital landscape in the pharma and life sciences industries. Throughout the workshop, attendees explored the basics of digital transformation for pharma and life sciences organizations and asked their questions during the Q&A session. Are you interested in partnership and our products? Drop us a line, and we will get back to you shortly.
Viseven CEO and Co-Founder Shares Her Breast Cancer Survivor Story Posted on October 31, 2023 by Andrii Nikulin Nataliya Andreychuk, the co-founder and CEO of Viseven, reveals her personal battle against breast cancer. Her story is a testament to enduring strength, tenacity, and sincere commitment to make a genuine difference in patients’ lives. For the first time, Nataliya courageously shared her story of overcoming breast cancer, inspiring others with her inner power and resilience. Five years later, she is finally ready to share the invaluable lessons she has learned: Nataliya shares her story five years after beating the disease “For a long time, I hesitated to share this deeply personal journey. The lines between personal and professional life can sometimes blur, and there’s a natural inclination to keep them separate. Yet, as the years have unfolded, I’ve come to realize that our personal experiences profoundly shape our professional paths. As humans, our personal and professional lives are inextricably linked. Today, marking the culmination of Breast Cancer Month, I share a chapter from my life – the story of Nataliya Andreychuk, a cancer survivor and the CEO of Viseven, a healthcare digital marketing agency rooted in Ukraine and dedicated to partnering with the Pharma and Life Sciences sectors. Five years ago, I was confronted with a diagnosis that no one ever wishes to hear – breast cancer. The journey that followed—filled with the courses of chemotherapy, surgeries, and radiation—tested me in ways I could never have imagined. Yet, throughout this tumultuous journey, I never once contemplated giving up. What fortified me during those trying times? The unwavering support of my family, friends, and notably, Viseven. Work became a sanctuary, a semblance of normalcy in a world turned upside down. Viseven wasn’t just a company to me; it was an extension of my family, an anchor in the storm. My journey through treatment also brought a profound realization. I began to truly understand the indispensable value that our Pharma and Life Sciences clients bring to countless lives. Trusting the medications they produce, I felt a deep and personal connection to our clients. Today, five years later, I stand here, more grateful for each day and with a fervent desire to inspire the others battling cancer. My journey, underscored by love, trust, and the insatiable will to live, should serve as a beacon of hope to all facing life’s formidable challenges. I owe a debt of gratitude to Lisod, the Israeli Oncology Clinic in Ukraine, and Andrii Zhygulin (LinkedIn Profile). Their tireless efforts quite literally gave me a second lease on life.” For nearly a decade, Nataliya Andreychuk has been at the forefront of transforming the pharmaceutical industry. Merely a few months prior to Nataliya’s diagnosis, the Viseven team was involved in the development of an oncology assistant mobile application. Together with the client, they were creating a credible source of evidence-based information for oncologists. Nataliya regards herself fortunate to be well-informed about the disease, its consequences, treatment alternatives, etc. Now, she firmly believes that timely, up-to-date, and reliable information can impact clinical outcomes, significantly increasing patients’ survival rates. The company’s mission to save lives by improving communication has become Nataliya’s personal guiding principle. Her recovery from breast cancer has not only deepened her connections with clients but also amplified the advocacy for patients’ needs. In sharing her story, she hopes to raise awareness about the importance of putting patients at the center of any healthcare efforts. Nataliya is convinced that pharmaceutical companies should approach each patient as an individual with unique circumstances and distinct needs. By embracing patient-focused marketing strategies, companies can create more meaningful connections with patients, leading to increased trust, higher compliance rates, and, eventually, improved healthcare outcomes. About Viseven Viseven is a future-inspired global Pharma marketing agency with more than a decade of experience. Viseven’s digital transformation center offers innovative solutions for companies of different sizes and digital maturity levels by merging marketing and digital technology expertise with innovation and strategic capabilities. The company’s solutions, products, and services are actively used by the TOP 100 Pharma and Life Sciences companies in more than 50 countries around the globe. Follow Viseven on social media: LinkedIn, Twitter, YouTube, and Facebook.
Viseven at Digital Pharma East 2023: Contributing to the Future Posted on October 5, 2023 by Andrii Nikulin On September 11-14, Viseven visited Philadelphia, USA, to attend Digital Pharma East – one of the leading conferences dedicated to the technological advancement in pharma, healthcare, and biotech. Digital Pharma East is a captivating event for professionals who want to improve their expertise in advertising, sales, brand marketing, customer experience, digital marketing, PR, product marketing, social media, and strategic operations. For four days of Digital Pharma East 2023, over 1200 attendees had an opportunity to join over 60 sessions hosted by more than 150 speakers who brought the latest insights about technology and innovation in the pharmaceutical and life sciences industries, including artificial intelligence, machine learning, and big data. At the panels, attendees learned more on the digitalization of their promotional possibilities in today’s healthcare landscape. The audience discovered how to improve customer experience, build engaging patient journeys, enhance collaboration between marketing and sales, increase omnichannel maturity, work with data, use addressable TV advertising, engage customers with storytelling, and beyond. The Viseven delegation to Digital Pharma East 2023 included Nataliya Andreychuk, Viseven CEO and Leonardo Sanchez, AE Lead at Viseven. For Viseven, it was a big honor to attend the event as one of the bronze partners. The Viseven team engaged with representatives of many pharma and biotech companies, solution providers, and agencies to highlight AI-powered functionality of eWizard content experience platform and how it can help produce more medical content faster without losing high quality. On the third day of the event, Nataliya Andreychuk, CEO at Viseven, hosted the panel discussion called Utilize Programmatic Marketing to Optimize Digital Advertising Across New Media Channels accompanied by: Stephanie Douglas, Director, US General Medicines Omnichannel Media, Sanofi Lori Holland-Hancock, Director Channel Strategy & Engagement Team, Oncology, Merck Gaetan Akinrolabu, Director, Corporate Social and Digital Media – Strategy, Channels & Content, Mirati Therapeutics Karin Hayes, Senior Vice President, Analytics Products and Services, Medicx At the panel, Nataliya discussed with co-hosts the overwhelming role of AI in today’s digital advertising, revealed the latest trends in personalized advertising, and suggested how to maintain compliance when delivering personalized ads and how to use them effectively and efficiently. It was a very insightful discussion. I’m really excited about how artificial intelligence is transforming the healthcare, pharma, and biotech industries. And it’s crucial for Viseven to attend events like Digital Pharma East, discover the latest trends, and share own experience related to advanced technology.Nataliya Andreychuk, CEO at Viseven Digital Pharma East 2023 was a fantastic event for the Viseven team. Our representatives were pleased to connect with other professionals enthusiastic about the digital future of marketing in healthcare, biotech, and pharma. If your company or agency needs advice on how to prepare for this future, don’t hesitate to contact us right now! An expert from the Viseven team will get back to you shortly to discuss potential partnership or give answers to any questions you have.
Viseven Attends Veeva APAC Commercial Summit 2023 Posted on October 3, 2023 by Andrii Nikulin On September 11, Viseven was in Singapore to visit magnificent Marina Bay Sands resort and take part in Veeva APAC Commercial Summit 2023 as one of the silver sponsors. Veeva APAC Commerical Summit is one of the most prominent events in the Asia-Pacific region where leading companies in biopharma connect, share professional expertise, network, and have fun. Viseven and Veeva have been partners for many years, providing advanced technology and content expertise to pharma and life sciences businesses and agencies of all sizes, and it was a big honor and privilege for the Viseven team to be at the event and make its own contribution to the evolution of biopharma digital marketing. At the summit, the Viseven delegation included three incredible professionals who were thrilled to represent the company at own booth: Rona Mortega, Senior Account Manager at Viseven Nathaniel Manzano, AE Lead at Viseven Rajan Gupta, Account Executive at Viseven Any event hosted by Veeva is a massive and fascinating affair that gathers marketing and sales professionals from different areas of the pharmaceutical and life sciences industries. This year’s APAC Commercial Summit was no exception. Over 1,000 attendees from over 140 biopharma companies had an opportunity to attend over 130 diverse sessions from four zones: Analytics & Execution, Content Transformation, Field Excellence, and Frictionless Engagement. The summit’s agenda included panels hosted by Veeva experts who shared new updates and insights about Veeva products and services, including Veeva CRM Suite, Veeva CRM Events Management Veeva Align, and Veeva Vault PromoMats. Additionally, attendees could join sessions featuring top pharma enterprises such as Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Takeda, AbbVie, Novartis, and Roche. The companies shared their experience in modular content, customer-centricity, actionable segmentation and targeting, field-executed email campaigns, commercial analytics, content localization, digital asset management, and many other topics. Viseven employees were pleased to know the latest news and techniques on Veeva products and services, get knowledge from the major players in the biopharma market, and have in-person chats with colleagues about their workflows, lifestyles, and interests. Along with attending panel discussions and keynotes sessions, the Viseven team successfully fulfilled its networking opportunities and met representatives of different pharma companies to show the benefits of mutual collaboration. Viseven demonstrated its potential partners eWizard content experience platform and highlighted the functionality their companies needed to optimize content operations and improve customer experience. Also, the companies Viseven engaged with showed their interest in Viseven Digital Content Factory and Viseven services, including omnichannel marketing and data analytics. Looking back on our participation in Veeva APAC Commercial Summit 2023 in Singapore, it has been an exceptional journey. We’re eager to foster the relationships we’ve cultivated and seek new opportunities to let Viseven make a meaningful impact in driving the prosperity and achievements of our valued industry collaborators!Nathaniel Manzano, AE Lead at Viseven Viseven was excited to participate in the summit and unlock numerous opportunities and promising horizons. The engagement with industry leaders from across the APAC region has broadened Viseven business network and unveiled exciting possibilities for future collaborations.
Rethinking Pharma Procurement Strategies Posted on September 14, 2023 by Andrii Nikulin Pharmaceutical procurement is arguably the key factor influencing drug availability, safety, and total costs. Comprehensive procurement process should ensure a timely supply of the right pharmaceutical in the right quantity, meeting approved quality standards. It should effectively manage supplier relationships in an ethical way while also seeking to secure the most favorable purchase price. That said, it is essential that this process was implemented by competent personnel with pharmaceutical, managerial, legal, and financial expertise. Equally important is their access to robust technology and reliable, up-to-date information. To tick all the boxes on this extensive list of requirements, pharmaceutical companies should clearly understand all challenges and remain aware of current trends to make procurement both efficient and seamless. In this article, the Viseven team aims to explain how pharma procurement works and to cover effective strategies to transform this process at any level, from local campaigns to national health programs. What is Procurement in the Pharmaceutical Industry? Pharmaceutical procurement refers to the process of managing supplier relationships to ensure pharma companies receive correct medicines in the right quantities at reasonable prices while the supplier gets a transparent and timely payment. The procurement cycle presupposes all decisions related to selecting suppliers and monitoring drug delivery and distribution. It typically falls into the following steps: Reviewing drug selections. Determining drug quantities. Aligning needs with the budget. Selecting a procurement method. Choosing suppliers. Outlining contract terms. Tracking order status. Receiving and checking drugs. Paying for an order. Distributing pharmacy. Gathering consumption information. Key Pharma Procurement Challenges There are many balls in the air which pharma brands must keep juggling to deliver effective, safe, and reasonably priced essential pharmacy. Let’s take a closer look at some of them. The lack of supply chain transparency The lack of supply chain visibility makes it excruciatingly challenging for pharma companies to plan medicine production, forecast demand, and manage their inventory. Without consistent, standardized data, regulators fail to identify drug supply concerns, policymakers cannot make informed decisions to improve supply chain resilience, and healthcare providers (HCPs) are blindsided by the acute shortage of critical pharmaceuticals. The lack of transparency is positively correlated with improper security as well, as it becomes problematic for buyers to protect medicines they cannot track. Poor supplier performance Poor supplier performance generally results in unanticipated expenses. For example, a pharmaceutical brand can face increased acquisition costs if a supplier has not delivered on time. It also bears extra replacement expenses when drugs are discarded due to improper packaging. Hidden expenses can pile up, spiraling out of control due to many reasons related to supplier performance: the lack of appropriate documentation, storage, wrong dosage forms, and the list goes on. Any of these performance incidents may create a serious disruption at any level of the supply chain. If inadequately managed, poor supplier performance may impact drug safety and availability. Unexpected geographic factors Many pharmaceutical companies relying on global markets for drug materials are particularly vulnerable to shifting geopolitical situations. For instance, depending on sources in tariff-affected countries can substantially increase a pharma company’s operational expenses. Climate change is another factor, potentially disrupting supplies and contributing to hefty price tags. Regions which were once the sources of raw materials may be plagued by adverse weather events, hindering production and causing inflated costs. What are the Main Pharmaceutical Procurement Methods? Procurement methods, at any health system level, typically comprise the following categories: restricted tender, open tender, direct procurement, competitive negotiation, and international and local shopping. Restricted tender: Suppliers must go through the prequalification process to prove their past supplier performance, manufacturing practices, and financial viability. Open tender: Any supplier representative can submit their offer, following terms and conditions outlined in the tender invitation. Direct procurement: Drugs or materials are sourced from a single supplier at the negotiated discount or quoted list price. Competitive negotiation: The buyer turns to a limited number of suppliers (usually at least three) to negotiate the price or achieve certain service arrangements. International or local shopping: Like competitive negotiation, the company reaches out to three suppliers on average; however, price negotiations are not allowed. Logistics Solutions to Improve Pharmacy Procurement Process With the rising number of sensitive medicines, how can the pharmaceutical logistic cycle keep expenses down while still complying with all safety requirements? Let’s discover the main approaches to accomplish this. Implementing innovative technologies Cutting-edge drugs, such as stem cell therapy or large molecule biologics, require innovative transportation methods to keep the damage risks close to zero. Technologies allow pharmaceutical companies to collect and analyze a massive amount of data to ensure proper drug safety. One of the most common use cases is Internet of Things (IoT) sensors placed on containers and packaging to track humidity and temperature in real-time. The importance of these solutions becomes all the more striking when one realizes that a staggering $35 billion is lost each year due to inadequate temperature regulation during shipments. Not only do sensors enable companies to comply with quality standards but also timely respond to risks during the actual transportation. For instance, technology makes it possible to modify a vehicle’s route or recharge the batteries in a temperature-controlled container, if necessary. Widening the scope of supply chain partners Expanding the network of suppliers is associated with tangible benefits, such as cost optimization and efficiency. For instance, a global life sciences (LS) company could choose to partner with their suppliers to perform safety tests. Instead of sending these materials to their own laboratory once they receive the packages, they could trust the tests done by the suppliers. By opting for this kind of collaboration, these companies can considerably trim off their transportation costs and speed up time-to-market. Collaborations with competitors or stakeholders in other industries can help address high costs of low volume drugs. Pharma brands can share trucks or temperature-controlled containers for airfreight, thereby significantly lowering transportation expenses. Digital Transformation in Pharma Procurement It is no secret that the coronavirus hit the health sectors the hardest. The pharmaceutical industry had to quickly find ways to optimize its procurement processes in order to tackle the hurdles the deadly virus brought upon businesses. Data analytics, e-procurement platforms, and blockchain technology emerged as the major trends to prevent procurement disruptions and boost supply chain resilience. Data analytics There is a reason data is called the new gold. For example, data analytics tools help businesses make more informed decisions regarding supplier negotiations. To choose the best supplier, businesses can analyze hundreds of options and sort them out in strategically important clusters. This categorization allows them to settle down on the right vendor based on the prices and upcoming purchases. Having the best supplier for a particular situation cuts down the total costs and time spent on negotiations. Artificial intelligence (AI) algorithms also take a lot of legwork from supplier management. Take, for instance, a pharma company that purchases ingredients for its new medicine. It has 200 suppliers in 120 strategically important clusters, with each supplier in numerous clusters. Advanced analytics solutions give the company a bird-eye view of each vendor’s performance in terms of quality, risks, price, and sustainability. Additionally, many companies introduce data analytics technology to cut down their transportation costs. To give you an example, a pharmaceutical manufacturer, Moderna, relies on Looker, an AI-powered data analytics solution delivered by Google. The following tool allows them to identify the most cost-saving logistics route for each of their 60,000 shipments per year. E-procurement platforms Pharmaceutical and LS enterprises leverage e-procurement solutions for a plethora of reasons. These include enhancing strategic planning, driving operational performance, and automating labor-intensive tasks. The range of functionalities within e-procurement platforms notably varies. Certain platforms focus on facilitating compliance with regulatory benchmarks, while others, much like well-known sites such as Amazon or eBay, connect users with verified suppliers, distributors, and manufacturers. Additionally, some digital solutions are designed to help to classify medications and store relevant details about them, such as active ingredients, dosage forms, and pricing. This not only saves a fair bit of time but also eliminates errors from the manual process of cataloging. Prior to e-procurement, GlaxoSmithKline (GSK), a global pharma brand, used old school paper cataloguing and communications over the phone. This made the procurement process more expensive, time-consuming, and ridden with errors. Soon they realized they needed to shift to an e-procurement platform to easily manage content in any lab supply firm worldwide. Their solution now allows them to create requisition, approve, distribute, and make receipts with just a few clicks. Blockchain technology Blockchain remains one of the main tech stories in pharmaceutical procurement. Blockchain refers to a secure database, where real-time information is available to all parties. This, in turn, makes it possible to share anything valuable, including drug provenance or current temperature, improving supply chain safety and transparency. For example, blockchain is actively used to monitor every step in the cold chain, from manufacturing to delivery, using smart contracts. If specific conditions are met, these contracts are automatically put into effect. This way, pharmaceutical companies can determine the step in the drug delivery process when a temperature-sensitive product becomes degraded. If fluctuation in temperature occurs, they can identify those responsible for the damage and request compensation. Since the record in the ledger cannot be manipulated or erased, blockchain helps to address another elephant in the room – drug authenticity. In 2021, in North America alone, pharma companies suffered from 2,440 incidents of medicine counterfeiting. With blockchain, every step a pharmaceutical product takes in the supply chain journey is documented through an immutable record of events. Merck, one of the oldest pharma manufacturers, partners with IBM, Walmart, and accounting leader KPMG to take advantage of blockchain technology. To build trust with its customers, the company gets rid of any intermediary that disrupts transparent data flow in their supply chain. Due to blockchain, pharmacists and healthcare providers (HCPs) can use an application to track the vaccine packages and get the full history of their journey, from suppliers to their offices. Ensure a painless pharmaceutical procurement process With rising incidents of counterfeiting, safety concerns, and high production costs, pharma companies absorb a disturbing realization: regulatory compliance alone will not solve all problems in the procurement process. It will require investments in cutting-edge technologies to ensure supply chain visibility, supplier high performance as well as resilience in the face of unanticipated geopolitical shifts. Viseven, with over 14 years of experience, has consistently delivered innovative digital solutions to pharmaceutical and LS enterprises worldwide. Over this period, we have established long-term partnerships with more than 150 clients, including 50 globally renowned industry leaders. From idea to realization, we can help to build procurement solutions of any complexity. Need a hand with software development? Please, contact our team to start cooperation.
Viseven at CPHI Korea to Witness Growth and Evolution in Pharma Posted on September 7, 2023 by Andrii Nikulin On August 30 – September 1, the Viseven team, including Yiseo Cheon, Account Manager, and Suyoung Kim, SDR Team Lead, attended CPHI Korea, one of the main conferences facilitating Korean pharma’s evolution. CPHI is a global platform that unites over 100,000 professionals from the pharmaceutical industry, hosting events in Spain, North America, the Middle East, India, Southeast Asia, Japan, and Korea. The events cover every step of the pharma supply chain: ingredients, machinery, equipment, technology, package and contract service suppliers, distributors, and buyers from the pharmaceutical industry. This year at CPHI Korea, over 300 exhibitors represented 14 industries: active pharmaceutical ingredients (APIs) generic APIs custom manufacturing intermediates, fine and specialty chemicals excipients finished dosage forms pharmaceutical machinery & technology laboratory and analytical equipment biopharmaceuticals pharmaceutical packaging natural extractscontract services health ingredients food ingredients The conference agenda included five sessions about the Korea Drug Research Association’s innovation policy, ingredients, sustainable API production, the US dietary supplement industry, and the global business expansion of biotech companies. Additionally, attendees had an opportunity to visit over 20 exhibitor seminars conducted based on unique case studies and research. Yiseo Cheon, Account Manager, and Suyoung Kim, SDR Team Lead, visited CPHI Korea to meet numerous local pharmaceutical and biotech companies that aim to expand from the local to the global market, including Europe and America. The Viseven team engaged with individuals in the medical industry from over 60 companies in Korea. The team’s main goal at the event was to meet local medical companies in advance and explore their needs. During interactions with a wide range of medical and biotech companies, we noticed that most local biotech companies require our digital marketing and design services, such as 2D and 3D videos and printed materials in English. The reason for this demand is their intention to develop and promote their biotechnology on a global scale,” Yiseo Cheon, Account Manager at Viseven. While there are a few local marketing design agencies in Korea, the expertise and specialized services offered by Viseven in the medical industry left a strong impression on local biotech companies in Korea. At the event, the Viseven team showcased its services using portfolio presentation and medical animation videos. After the event, one of the local biotech companies in Korea agreed to acquire the design service.
Viseven at PhilMedical Expo 2023: Observing the Innovation Posted on September 5, 2023 by Andrii Nikulin On August 23-25, the Viseven team visited Manila, the capital of Philippines to attend PhilMedical Expo – an international exhibition on hospital, laboratory, pharmaceutical, and medical equipment and supplies. At the 6th edition of Phil Medical Expo, professionals of all sorts gathered to drive health frontiers and bridge science, fitness, and medical technology. At the panel that included almost 30 conference speakers and nearly 20 workshop and seminar speakers, attendees had an opportunity to discuss various topics, including the Philippine consumer health industry, the role of physical therapy for athletes, quality in progressive laboratory medicine, and beyond. Nathaniel Manzano, Account Executive Lead at Viseven, and Christine De Real, Account Executive at Viseven, spent two days in the atmosphere of innovation to see the latest developments in the healthcare and pharmaceutical industries. Along with attending a few noteworthy workshops, Nataniel and Christine met dozens of professionals representing various businesses in the Philippines and Asia-Pacific. At multiple booths, companies demonstrated products and services that transform today’s medicine. “It was a great event. We walked from booth to booth to network with the exhibitors, chat with them, discover what they offer, and also exchange insights about our services,” says Christine De Real, Account Executive at Viseven. Nathaniel Manzano and Christine De Real connected with representatives of a few companies from China, Korea, Japan, and Pakistan to share insights, showcase Viseven services, and uncover avenues for potential partnership and collaboration. Potential partners were discovering how their teams can implement advanced omnichannel techniques in their marketing strategies without wasting resources. “Our primary goal now was to promote Viseven as a global MarTech agency for pharma & life sciences and strengthen its position in the APAC region. The Philippines is one of the region’s most promising and fastest-growing pharma markets. We’re glad to connect with other professionals and do business with them at PhilMedical Expo 2023,” says Nathaniel Manzano, Account Executive Lead at Viseven. The participation of the Viseven team at the 6th edition of PhilMedical Expo has opened doors to many opportunities and promising prospects. After interacting with multiple industry leaders, Viseven expanded its business network in the APAC region and successfully nurtured the connections.
Salesforce & Mobile App Integration for interacting Healthcare Community Posted on August 23, 2023 by Andrii Nikulin Client Profile: Industry: PharmaceuticalLocation: USASize: 37,000+ Technology: IOS, WindowsPlatform: Salesforce Company Bio The client is a global healthcare company empowering people worldwide to live healthier at every stage of life. They provide access to medicines, advance sustainable operations, develop innovative solutions and leverage collective expertise to connect more people to more products and services. Project Overview The client was looking to create a unified system for collecting requests from medical reps to effectively engage with HCPs. As a global pharmaceutical company, it was important for the client to unify these processes since the rules and regulations governing HCP engagement vary from one country to another, and it is necessary for the client to remain compliant. Why Viseven? Viseven actualized many successful projects for the clients in the past, such as various Myforce CRM customizations as well as projects involving eDetailer and eWizard. The client was very pleased with the services we provided and did not hesitate to approach us with a new custom software development project. Business Challenge While creating a unified system for collecting requests from medical reps for engaging with HCPs is not a big challenge in and of itself, the project became more complex as we went along. One of the complications was that the client did not have a detailed vision and understanding of the functionality of the tool, which meant that we would need to gather the requirements ourselves, depending on the business needs. In addition to this, we needed to implement complex system-to-system integrations while maintaining strict legal compliance with laws and regulations in 50 countries. All of this needed to be developed from scratch, starting with the business owner’s idea and all the way to roll-out and support. The end solution would be rolled on in 6 stages across 50 European countries. Solution Delivered to the Client Viseven developed a product called the Handy Tool, which works on the web inside Salesforce as well as on mobile applications for iOS and Windows. Medical reps can create requests in the Handy Tools and the system dynamically shows all the fields which need to be filled in and automatically identifies approvers for each of the requests. There is also an approval flow automation, which helps speed up processes of signing the docs, approval from direct managers/supervisors and from different functions, like Finance, Medical, and Legal, for a given interaction Our business analyst and project manager gathered all of the requirements from the client while meeting strict development timelines for the development of each feature. Communication was maintained with key stakeholders via agreed regular meetings and emailed status reports. A communication plan was developed during the Project Planning phase and agreed upon with business stakeholders, such as the product owner and project sponsor. Viseven provided a dedicated Project Manager who maintained all ongoing communication with the client. All discovered risks and problems were discussed during the regular status check meetings and presented to key stakeholders. Results So, what we have done? Here are the main points, which we are proud of in this Salesforce healthcare case study: Salesforce & Mobile App IntegrationRelieved Adaptation of Med Reps to RegulationsReduced Manual WorkDocumentation AutomationAutomated Approval FlowsSystem-to-system Integrations with Legal Compliance in 50 countries Use the form below to request a case study in PDF format and learn about IT software, designed to support processes for interacting with the healthcare community.
Viseven at Pharma Xchange: Switching to Omnichannel in Korea Posted on August 3, 2023 by Andrii Nikulin Starting this year, most pharmaceutical companies in South Korea plan to switch from multichannel to omnichannel marketing with the help of content production, cross-functional change management, and effective KPI monitoring. Viseven actively keeps an eye of the latest transformations within the South Korean pharmaceutical market, as it receives investments that amounts to trillions South Korean won. One of the tremendous opportunities we use to see the changes in pharma in South Korea is networking. On June 30, 2023, the Viseven team were pleased to attend Pharma Xchange, an event about omnichannel marketing, technology, and innovation in the pharmaceutical industry. At the conference, 16 top global pharmaceutical companies and medical-related partners in South Korea had a great chance to attend a few sessions hosted by: Yuri Jung, Co-Founder and CEO at SO & Company Reina Kim, Commercial Strategy Manager at SO & Company Jina Oh, Managing Director at Medigate The Viseven team, which included Yiseo Cheon, Account Manager, and Suyoung Kim, SDR Team Lead, went to the event to engage with companies that already use eWizard, a content experience platform powered by Viseven. Yiseo and Suyoung connected with representatives of Takeda Korea, Boehringer Ingelheim Korea, Bristol Myers Squibb Korea, Viatris Korea, Bayer Korea, SO & Company, and Medigate, who got interested in Viseven products and services. “Due to the nature of Korean people who are sensitive to trends, many people at the event knew about the eWizard solution from Viseven. They showed interest in the omnichannel consulting service. We look forward to innovative changes in the digital marketing of Korean pharmaceutical companies!”,—Yiseo Cheon, Account Manager at Viseven South Korea. Along with meeting many current customers and new prospects who wanted to know how they could implement an omnichannel strategy within their organization, Yiseo and Suyoung were excited to participate in a discussion of innovation in South Korean pharma. Here’s how they compare this experience with the knowledge they had before the pandemic: “The Viseven Korean team learned about the changes in digital marketing strategies of Korean pharmaceutical companies before and after Covid-19. It was a very important experience for us because we had a session to hear opinions on the current digital marketing trends in the Korean market and the importance of using an omnichannel marketing strategy.” At the end of the event, attendees had an opportunity to take part in a panel discussion Omnichannel Strategy: Review & Outlook hosted by four speakers: Hoon Park, Sr. Customer Excellence Manager at Janssen Korea [Moderator] Euijoong Pyo, Omnichannel Customer Engagement Manager at Jannsen Korea Hajun Sung, Omnichannel Engagement Manager at BMS Media Jongil Park, Multichannel Engagement Specialist at Boehringer Ingelheim Korea During one hour of conversation, panel hosts shared experiences within their organizations and answered the audience’s questions. You are always welcome to get in touch and find out more about Viseven products and services, industry events, or special offers. Feel free to send us a request anytime.
Viseven at Collision 2023 Posted on July 26, 2023 by Andrii Nikulin Collision is one of the world’s biggest tech conferences where businesses, leaders, investors, designers, developers, marketers, media, innovation enthusiasts, and artificial intelligence (AI) evangelists engage with each other, share knowledge, and learn how technology is transforming global business. The event’s schedule was massive. Attendees met representatives of nearly 1,500 startups from Australia, Canada, Egypt, India, South Korea, Portugal, the United Kingdom, and the United States. More than 630 speakers from 27 industries moderated talks, masterclasses, and Q&A sessions about dozens of topics: advertising, AI, machine learning, back-end development, cars, mobility, climate change, content creation, crypto, data science, e-commerce, education, energy, ethics, finance, fintech, payments, front-end development, fundraising, future of work, gaming, virtual reality (VR), augmented reality (AR), hardware, robotics, health, HR, recruitment, investment, leadership, marketing, media, mobile development, politics, PR, communications, privacy, security, retail, trade, software as a service (SaaS), sales, scaling, smart cities, social media, society, and sport. Yuliya Sotska, Chief Brand & Communication Officer, Sergii Tatarchuk, Head of Digital, Michael DePalma, Head of Client Engagement, and Maksym Savenko, AD/AM Lead from the Viseven team attended Collision 2023 on June 26-29, 2023. Here’s how Sergii Tatarchuk, Head of Digital at Viseven, comments the scale of the event: “One shouldn’t try to attend all the Collision events alone because such a rich flow of information will simply overwhelm you. Projects and companies send fully-fledged teams, where everyone has their own task, and this is probably the only correct decision for such events.” At booth #B502, Viseven demonstrated eWizard, a content experience platform that helps pharma and life sciences companies create in-depth, personalized customer experiences. The Viseven team showed the attendees the platform’s functionality, answered questions about the platform’s capabilities, and provided information on the plans of Viseven to improve digital maturity in the pharmaceutical and life sciences industries. “Our team spent three exciting and productive days at our booth at the conference. We’re grateful to represent Viseven, got a lot of new experience, and met many people interested in eWizard,”—Yuliya Sotska explained. Each member of the Viseven team saw many great panels of other companies, connected with many great people in pharmaceutical and other industries, and heard many great ideas about the implementation of advanced technology such as artificial intelligence and automation. On the last day of the conference, Yulia Sotska moderated two panels: Breaking Binary: The Future of LGBTQ+ Care with Liana M Douillet Guzmán, CEO at Folx Heath. Quest of Human Immortality with Joel Jackson, President & Co-Founder of Lifeforce, and Amol Sarva, Managing Partner at Life Extension Ventures. “We delved into some very important topics concerning 2SLGBTQIA+ healthcare with the amazing Liana M. Douillet Guzmán. I also had a fascinating chat on living forever and the quest for human immortality with the brilliant minds of Joel Jackson and Amol Sarva,”—says Yuliya Sotska. Do you need more details about the eWizard content experience platform, or do you want to discuss partnership opportunities with Viseven? Please contact us, and we’ll get back to you shortly.
